nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2E1—Parkinson's disease	0.483	1	CbGaD
Sevoflurane—GRIA1—cerebellar cortex—Parkinson's disease	0.0112	0.0516	CbGeAlD
Sevoflurane—GRIA1—telencephalic ventricle—Parkinson's disease	0.00652	0.03	CbGeAlD
Sevoflurane—GABRQ—nerve—Parkinson's disease	0.00454	0.0209	CbGeAlD
Sevoflurane—KCNK10—hindbrain—Parkinson's disease	0.00423	0.0195	CbGeAlD
Sevoflurane—KCNK9—hindbrain—Parkinson's disease	0.0042	0.0193	CbGeAlD
Sevoflurane—GRIA1—nerve—Parkinson's disease	0.00411	0.0189	CbGeAlD
Sevoflurane—KCNA1—nerve—Parkinson's disease	0.00401	0.0185	CbGeAlD
Sevoflurane—GRIA1—hindbrain—Parkinson's disease	0.00308	0.0142	CbGeAlD
Sevoflurane—KCNA1—hindbrain—Parkinson's disease	0.003	0.0138	CbGeAlD
Sevoflurane—ATP2C1—nerve—Parkinson's disease	0.00281	0.0129	CbGeAlD
Sevoflurane—KCNK18—spinal cord—Parkinson's disease	0.00271	0.0125	CbGeAlD
Sevoflurane—KCNK10—brainstem—Parkinson's disease	0.00242	0.0112	CbGeAlD
Sevoflurane—KCNK9—brainstem—Parkinson's disease	0.00241	0.0111	CbGeAlD
Sevoflurane—GABRA6—hindbrain—Parkinson's disease	0.00236	0.0109	CbGeAlD
Sevoflurane—KCNK9—forebrain—Parkinson's disease	0.00232	0.0107	CbGeAlD
Sevoflurane—KCNK18—nervous system—Parkinson's disease	0.00228	0.0105	CbGeAlD
Sevoflurane—KCNK18—central nervous system—Parkinson's disease	0.0022	0.0101	CbGeAlD
Sevoflurane—ATP5D—hindbrain—Parkinson's disease	0.00213	0.00981	CbGeAlD
Sevoflurane—GLRA1—nervous system—Parkinson's disease	0.00212	0.00977	CbGeAlD
Sevoflurane—KCNK3—forebrain—Parkinson's disease	0.00211	0.00972	CbGeAlD
Sevoflurane—GLRA1—central nervous system—Parkinson's disease	0.00204	0.0094	CbGeAlD
Sevoflurane—GABRQ—forebrain—Parkinson's disease	0.00188	0.00866	CbGeAlD
Sevoflurane—KCNK3—cardiovascular system—Parkinson's disease	0.00179	0.00822	CbGeAlD
Sevoflurane—GRIA1—brainstem—Parkinson's disease	0.00176	0.00812	CbGeAlD
Sevoflurane—GABRB2—hindbrain—Parkinson's disease	0.00174	0.008	CbGeAlD
Sevoflurane—KCNA1—brainstem—Parkinson's disease	0.00172	0.00792	CbGeAlD
Sevoflurane—GRIA1—forebrain—Parkinson's disease	0.0017	0.00783	CbGeAlD
Sevoflurane—KCNA1—forebrain—Parkinson's disease	0.00166	0.00764	CbGeAlD
Sevoflurane—GABRA2—hindbrain—Parkinson's disease	0.00159	0.00731	CbGeAlD
Sevoflurane—GABRA1—hindbrain—Parkinson's disease	0.00153	0.00706	CbGeAlD
Sevoflurane—ND1—forebrain—Parkinson's disease	0.00146	0.00674	CbGeAlD
Sevoflurane—GABRD—forebrain—Parkinson's disease	0.00136	0.00628	CbGeAlD
Sevoflurane—GABRA6—brainstem—Parkinson's disease	0.00135	0.00623	CbGeAlD
Sevoflurane—KCNK10—head—Parkinson's disease	0.00134	0.00616	CbGeAlD
Sevoflurane—KCNK9—head—Parkinson's disease	0.00133	0.00613	CbGeAlD
Sevoflurane—GABRG1—forebrain—Parkinson's disease	0.00131	0.00605	CbGeAlD
Sevoflurane—KCNK10—nervous system—Parkinson's disease	0.00127	0.00584	CbGeAlD
Sevoflurane—GABRA5—forebrain—Parkinson's disease	0.00127	0.00583	CbGeAlD
Sevoflurane—KCNK9—nervous system—Parkinson's disease	0.00126	0.00581	CbGeAlD
Sevoflurane—ND1—cardiovascular system—Parkinson's disease	0.00124	0.0057	CbGeAlD
Sevoflurane—GRIA1—medulla oblongata—Parkinson's disease	0.00123	0.00566	CbGeAlD
Sevoflurane—KCNK10—central nervous system—Parkinson's disease	0.00122	0.00563	CbGeAlD
Sevoflurane—ATP5D—brainstem—Parkinson's disease	0.00122	0.00563	CbGeAlD
Sevoflurane—KCNK9—central nervous system—Parkinson's disease	0.00122	0.00559	CbGeAlD
Sevoflurane—KCNK3—head—Parkinson's disease	0.00121	0.00556	CbGeAlD
Sevoflurane—KCNK10—cerebellum—Parkinson's disease	0.00119	0.0055	CbGeAlD
Sevoflurane—KCNK9—cerebellum—Parkinson's disease	0.00119	0.00547	CbGeAlD
Sevoflurane—ATP5D—forebrain—Parkinson's disease	0.00118	0.00543	CbGeAlD
Sevoflurane—ATP2C1—forebrain—Parkinson's disease	0.00116	0.00536	CbGeAlD
Sevoflurane—GABRA4—forebrain—Parkinson's disease	0.00115	0.00529	CbGeAlD
Sevoflurane—KCNK3—nervous system—Parkinson's disease	0.00115	0.00528	CbGeAlD
Sevoflurane—GRIA1—midbrain—Parkinson's disease	0.00112	0.00517	CbGeAlD
Sevoflurane—KCNK3—central nervous system—Parkinson's disease	0.0011	0.00508	CbGeAlD
Sevoflurane—KCNA1—midbrain—Parkinson's disease	0.0011	0.00505	CbGeAlD
Sevoflurane—GRIA1—spinal cord—Parkinson's disease	0.0011	0.00505	CbGeAlD
Sevoflurane—GABRQ—head—Parkinson's disease	0.00108	0.00496	CbGeAlD
Sevoflurane—KCNA1—spinal cord—Parkinson's disease	0.00107	0.00493	CbGeAlD
Sevoflurane—GABRQ—nervous system—Parkinson's disease	0.00102	0.0047	CbGeAlD
Sevoflurane—ATP5D—cardiovascular system—Parkinson's disease	0.000997	0.00459	CbGeAlD
Sevoflurane—GABRB2—brainstem—Parkinson's disease	0.000996	0.00459	CbGeAlD
Sevoflurane—GABRD—medulla oblongata—Parkinson's disease	0.000986	0.00454	CbGeAlD
Sevoflurane—ATP2C1—cardiovascular system—Parkinson's disease	0.000984	0.00453	CbGeAlD
Sevoflurane—GABRQ—central nervous system—Parkinson's disease	0.000983	0.00453	CbGeAlD
Sevoflurane—GRIA1—head—Parkinson's disease	0.000974	0.00448	CbGeAlD
Sevoflurane—KCNK10—brain—Parkinson's disease	0.000971	0.00447	CbGeAlD
Sevoflurane—KCNK9—brain—Parkinson's disease	0.000965	0.00444	CbGeAlD
Sevoflurane—GABRB2—forebrain—Parkinson's disease	0.000961	0.00443	CbGeAlD
Sevoflurane—GABRG2—forebrain—Parkinson's disease	0.000961	0.00443	CbGeAlD
Sevoflurane—KCNA1—head—Parkinson's disease	0.000951	0.00438	CbGeAlD
Sevoflurane—GABRG1—medulla oblongata—Parkinson's disease	0.000949	0.00437	CbGeAlD
Sevoflurane—GABRG3—head—Parkinson's disease	0.000944	0.00434	CbGeAlD
Sevoflurane—GRIA1—nervous system—Parkinson's disease	0.000924	0.00425	CbGeAlD
Sevoflurane—GABRB1—medulla oblongata—Parkinson's disease	0.00092	0.00424	CbGeAlD
Sevoflurane—GABRA2—brainstem—Parkinson's disease	0.00091	0.00419	CbGeAlD
Sevoflurane—KCNK2—brain—Parkinson's disease	0.000907	0.00417	CbGeAlD
Sevoflurane—KCNA1—nervous system—Parkinson's disease	0.000902	0.00415	CbGeAlD
Sevoflurane—GABRD—midbrain—Parkinson's disease	0.000901	0.00415	CbGeAlD
Sevoflurane—GABRG3—nervous system—Parkinson's disease	0.000895	0.00412	CbGeAlD
Sevoflurane—GRIA1—central nervous system—Parkinson's disease	0.000889	0.00409	CbGeAlD
Sevoflurane—GABRA1—brainstem—Parkinson's disease	0.00088	0.00405	CbGeAlD
Sevoflurane—GABRA2—forebrain—Parkinson's disease	0.000878	0.00404	CbGeAlD
Sevoflurane—KCNK3—brain—Parkinson's disease	0.000876	0.00403	CbGeAlD
Sevoflurane—GRIA1—cerebellum—Parkinson's disease	0.000869	0.004	CbGeAlD
Sevoflurane—KCNA1—central nervous system—Parkinson's disease	0.000868	0.004	CbGeAlD
Sevoflurane—GABRG1—midbrain—Parkinson's disease	0.000867	0.00399	CbGeAlD
Sevoflurane—GABRG3—central nervous system—Parkinson's disease	0.000861	0.00396	CbGeAlD
Sevoflurane—ATP5D—medulla oblongata—Parkinson's disease	0.000852	0.00392	CbGeAlD
Sevoflurane—GABRA1—forebrain—Parkinson's disease	0.000849	0.00391	CbGeAlD
Sevoflurane—KCNA1—cerebellum—Parkinson's disease	0.000848	0.00391	CbGeAlD
Sevoflurane—GABRG1—spinal cord—Parkinson's disease	0.000846	0.0039	CbGeAlD
Sevoflurane—GABRB1—midbrain—Parkinson's disease	0.000841	0.00387	CbGeAlD
Sevoflurane—ATP2C1—medulla oblongata—Parkinson's disease	0.000841	0.00387	CbGeAlD
Sevoflurane—ND1—head—Parkinson's disease	0.000838	0.00386	CbGeAlD
Sevoflurane—GABRB1—spinal cord—Parkinson's disease	0.000821	0.00378	CbGeAlD
Sevoflurane—ND1—nervous system—Parkinson's disease	0.000794	0.00366	CbGeAlD
Sevoflurane—GABRD—head—Parkinson's disease	0.000781	0.0036	CbGeAlD
Sevoflurane—GABRQ—brain—Parkinson's disease	0.000781	0.00359	CbGeAlD
Sevoflurane—ATP5D—midbrain—Parkinson's disease	0.000779	0.00359	CbGeAlD
Sevoflurane—ATP2C1—midbrain—Parkinson's disease	0.000769	0.00354	CbGeAlD
Sevoflurane—ND1—central nervous system—Parkinson's disease	0.000765	0.00352	CbGeAlD
Sevoflurane—ATP5D—spinal cord—Parkinson's disease	0.00076	0.0035	CbGeAlD
Sevoflurane—GABRG1—head—Parkinson's disease	0.000752	0.00346	CbGeAlD
Sevoflurane—ATP2C1—spinal cord—Parkinson's disease	0.00075	0.00345	CbGeAlD
Sevoflurane—GABRA6—head—Parkinson's disease	0.000748	0.00344	CbGeAlD
Sevoflurane—GABRD—nervous system—Parkinson's disease	0.000741	0.00341	CbGeAlD
Sevoflurane—GABRB3—forebrain—Parkinson's disease	0.000738	0.0034	CbGeAlD
Sevoflurane—GABRB1—head—Parkinson's disease	0.000729	0.00336	CbGeAlD
Sevoflurane—GABRA5—head—Parkinson's disease	0.000725	0.00334	CbGeAlD
Sevoflurane—GABRD—central nervous system—Parkinson's disease	0.000713	0.00328	CbGeAlD
Sevoflurane—GABRG1—nervous system—Parkinson's disease	0.000713	0.00328	CbGeAlD
Sevoflurane—GABRA6—nervous system—Parkinson's disease	0.000709	0.00326	CbGeAlD
Sevoflurane—GRIA1—brain—Parkinson's disease	0.000706	0.00325	CbGeAlD
Sevoflurane—GABRD—cerebellum—Parkinson's disease	0.000697	0.00321	CbGeAlD
Sevoflurane—GABRG2—medulla oblongata—Parkinson's disease	0.000695	0.0032	CbGeAlD
Sevoflurane—GABRB2—medulla oblongata—Parkinson's disease	0.000695	0.0032	CbGeAlD
Sevoflurane—GABRB1—nervous system—Parkinson's disease	0.000691	0.00318	CbGeAlD
Sevoflurane—KCNA1—brain—Parkinson's disease	0.000689	0.00317	CbGeAlD
Sevoflurane—GABRA5—nervous system—Parkinson's disease	0.000688	0.00317	CbGeAlD
Sevoflurane—GABRG1—central nervous system—Parkinson's disease	0.000687	0.00316	CbGeAlD
Sevoflurane—GABRG3—brain—Parkinson's disease	0.000684	0.00315	CbGeAlD
Sevoflurane—GABRA6—central nervous system—Parkinson's disease	0.000683	0.00314	CbGeAlD
Sevoflurane—GABRA3—head—Parkinson's disease	0.000675	0.00311	CbGeAlD
Sevoflurane—ATP5D—head—Parkinson's disease	0.000675	0.00311	CbGeAlD
Sevoflurane—GABRG1—cerebellum—Parkinson's disease	0.000671	0.00309	CbGeAlD
Sevoflurane—GABRA6—cerebellum—Parkinson's disease	0.000667	0.00307	CbGeAlD
Sevoflurane—ATP2C1—head—Parkinson's disease	0.000667	0.00307	CbGeAlD
Sevoflurane—GABRB1—central nervous system—Parkinson's disease	0.000666	0.00306	CbGeAlD
Sevoflurane—GABRA5—central nervous system—Parkinson's disease	0.000662	0.00305	CbGeAlD
Sevoflurane—GABRA4—head—Parkinson's disease	0.000658	0.00303	CbGeAlD
Sevoflurane—GABRP—head—Parkinson's disease	0.000653	0.00301	CbGeAlD
Sevoflurane—GABRB1—cerebellum—Parkinson's disease	0.000651	0.003	CbGeAlD
Sevoflurane—GABRA3—nervous system—Parkinson's disease	0.00064	0.00295	CbGeAlD
Sevoflurane—ATP5D—nervous system—Parkinson's disease	0.00064	0.00295	CbGeAlD
Sevoflurane—GABRB2—midbrain—Parkinson's disease	0.000635	0.00292	CbGeAlD
Sevoflurane—GABRG2—midbrain—Parkinson's disease	0.000635	0.00292	CbGeAlD
Sevoflurane—ATP2C1—nervous system—Parkinson's disease	0.000632	0.00291	CbGeAlD
Sevoflurane—GABRA4—nervous system—Parkinson's disease	0.000624	0.00287	CbGeAlD
Sevoflurane—GABRB2—spinal cord—Parkinson's disease	0.000619	0.00285	CbGeAlD
Sevoflurane—GABRG2—spinal cord—Parkinson's disease	0.000619	0.00285	CbGeAlD
Sevoflurane—GABRA3—central nervous system—Parkinson's disease	0.000616	0.00284	CbGeAlD
Sevoflurane—ATP5D—central nervous system—Parkinson's disease	0.000616	0.00284	CbGeAlD
Sevoflurane—GABRA1—medulla oblongata—Parkinson's disease	0.000613	0.00282	CbGeAlD
Sevoflurane—ATP2C1—central nervous system—Parkinson's disease	0.000608	0.0028	CbGeAlD
Sevoflurane—ND1—brain—Parkinson's disease	0.000607	0.00279	CbGeAlD
Sevoflurane—ATP5D—cerebellum—Parkinson's disease	0.000603	0.00277	CbGeAlD
Sevoflurane—GABRA4—central nervous system—Parkinson's disease	0.000601	0.00277	CbGeAlD
Sevoflurane—ATP2C1—cerebellum—Parkinson's disease	0.000595	0.00274	CbGeAlD
Sevoflurane—GABRA4—cerebellum—Parkinson's disease	0.000587	0.0027	CbGeAlD
Sevoflurane—GABRD—brain—Parkinson's disease	0.000566	0.00261	CbGeAlD
Sevoflurane—GABRA1—midbrain—Parkinson's disease	0.000561	0.00258	CbGeAlD
Sevoflurane—GABRB2—head—Parkinson's disease	0.000551	0.00253	CbGeAlD
Sevoflurane—GABRG2—head—Parkinson's disease	0.000551	0.00253	CbGeAlD
Sevoflurane—GABRA1—spinal cord—Parkinson's disease	0.000547	0.00252	CbGeAlD
Sevoflurane—GABRG1—brain—Parkinson's disease	0.000545	0.00251	CbGeAlD
Sevoflurane—GABRA6—brain—Parkinson's disease	0.000542	0.00249	CbGeAlD
Sevoflurane—GABRB3—medulla oblongata—Parkinson's disease	0.000533	0.00246	CbGeAlD
Sevoflurane—GABRB1—brain—Parkinson's disease	0.000529	0.00243	CbGeAlD
Sevoflurane—GABRA5—brain—Parkinson's disease	0.000526	0.00242	CbGeAlD
Sevoflurane—GABRB2—nervous system—Parkinson's disease	0.000522	0.0024	CbGeAlD
Sevoflurane—GABRG2—nervous system—Parkinson's disease	0.000522	0.0024	CbGeAlD
Sevoflurane—CYP2A6—cerebellum—Parkinson's disease	0.000508	0.00234	CbGeAlD
Sevoflurane—GABRA2—head—Parkinson's disease	0.000503	0.00232	CbGeAlD
Sevoflurane—GABRB2—central nervous system—Parkinson's disease	0.000503	0.00231	CbGeAlD
Sevoflurane—GABRG2—central nervous system—Parkinson's disease	0.000503	0.00231	CbGeAlD
Sevoflurane—GABRE—head—Parkinson's disease	0.000499	0.0023	CbGeAlD
Sevoflurane—GABRB2—cerebellum—Parkinson's disease	0.000491	0.00226	CbGeAlD
Sevoflurane—GABRG2—cerebellum—Parkinson's disease	0.000491	0.00226	CbGeAlD
Sevoflurane—GABRA3—brain—Parkinson's disease	0.000489	0.00225	CbGeAlD
Sevoflurane—ATP5D—brain—Parkinson's disease	0.000489	0.00225	CbGeAlD
Sevoflurane—GABRB3—midbrain—Parkinson's disease	0.000488	0.00224	CbGeAlD
Sevoflurane—GABRA1—head—Parkinson's disease	0.000486	0.00224	CbGeAlD
Sevoflurane—ATP2C1—brain—Parkinson's disease	0.000483	0.00222	CbGeAlD
Sevoflurane—GABRA4—brain—Parkinson's disease	0.000477	0.0022	CbGeAlD
Sevoflurane—GABRA2—nervous system—Parkinson's disease	0.000477	0.0022	CbGeAlD
Sevoflurane—GABRB3—spinal cord—Parkinson's disease	0.000476	0.00219	CbGeAlD
Sevoflurane—GABRE—nervous system—Parkinson's disease	0.000473	0.00218	CbGeAlD
Sevoflurane—GABRA1—nervous system—Parkinson's disease	0.000461	0.00212	CbGeAlD
Sevoflurane—GABRA2—central nervous system—Parkinson's disease	0.000459	0.00211	CbGeAlD
Sevoflurane—GABRE—central nervous system—Parkinson's disease	0.000455	0.0021	CbGeAlD
Sevoflurane—GABRA2—cerebellum—Parkinson's disease	0.000449	0.00207	CbGeAlD
Sevoflurane—GABRA1—central nervous system—Parkinson's disease	0.000444	0.00204	CbGeAlD
Sevoflurane—GABRA1—cerebellum—Parkinson's disease	0.000434	0.002	CbGeAlD
Sevoflurane—CYP2B6—cardiovascular system—Parkinson's disease	0.000423	0.00195	CbGeAlD
Sevoflurane—GABRB3—head—Parkinson's disease	0.000423	0.00195	CbGeAlD
Sevoflurane—CYP2A6—brain—Parkinson's disease	0.000412	0.0019	CbGeAlD
Sevoflurane—GABRB3—nervous system—Parkinson's disease	0.000401	0.00185	CbGeAlD
Sevoflurane—GABRB2—brain—Parkinson's disease	0.000399	0.00184	CbGeAlD
Sevoflurane—GABRG2—brain—Parkinson's disease	0.000399	0.00184	CbGeAlD
Sevoflurane—CYP2E1—cardiovascular system—Parkinson's disease	0.000397	0.00183	CbGeAlD
Sevoflurane—GABRB3—central nervous system—Parkinson's disease	0.000386	0.00178	CbGeAlD
Sevoflurane—GABRB3—cerebellum—Parkinson's disease	0.000377	0.00174	CbGeAlD
Sevoflurane—GABRA2—brain—Parkinson's disease	0.000364	0.00168	CbGeAlD
Sevoflurane—GABRE—brain—Parkinson's disease	0.000361	0.00166	CbGeAlD
Sevoflurane—GABRA1—brain—Parkinson's disease	0.000352	0.00162	CbGeAlD
Sevoflurane—CYP2E1—medulla oblongata—Parkinson's disease	0.000339	0.00156	CbGeAlD
Sevoflurane—ALB—brain—Parkinson's disease	0.000329	0.00152	CbGeAlD
Sevoflurane—GABRB3—brain—Parkinson's disease	0.000306	0.00141	CbGeAlD
Sevoflurane—CYP2E1—spinal cord—Parkinson's disease	0.000303	0.00139	CbGeAlD
Sevoflurane—CYP2B6—head—Parkinson's disease	0.000287	0.00132	CbGeAlD
Sevoflurane—CYP2B6—nervous system—Parkinson's disease	0.000272	0.00125	CbGeAlD
Sevoflurane—CYP2E1—head—Parkinson's disease	0.000269	0.00124	CbGeAlD
Sevoflurane—CYP2B6—central nervous system—Parkinson's disease	0.000262	0.0012	CbGeAlD
Sevoflurane—CYP2E1—nervous system—Parkinson's disease	0.000255	0.00117	CbGeAlD
Sevoflurane—CYP2E1—central nervous system—Parkinson's disease	0.000246	0.00113	CbGeAlD
Sevoflurane—CYP2E1—cerebellum—Parkinson's disease	0.00024	0.0011	CbGeAlD
Sevoflurane—CYP2B6—brain—Parkinson's disease	0.000208	0.000956	CbGeAlD
Sevoflurane—CYP3A4—nervous system—Parkinson's disease	0.000205	0.000945	CbGeAlD
Sevoflurane—CYP3A4—central nervous system—Parkinson's disease	0.000198	0.000909	CbGeAlD
Sevoflurane—CYP2E1—brain—Parkinson's disease	0.000195	0.000897	CbGeAlD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.03e-05	0.000168	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IL1B—Parkinson's disease	5e-05	0.000167	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	5e-05	0.000167	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.97e-05	0.000166	CbGpPWpGaD
Sevoflurane—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	4.89e-05	0.000163	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.83e-05	0.000161	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.77e-05	0.000159	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	4.64e-05	0.000155	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—MCCC1—Parkinson's disease	4.62e-05	0.000154	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ND3—Parkinson's disease	4.62e-05	0.000154	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—COMT—Parkinson's disease	4.55e-05	0.000152	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—COMT—Parkinson's disease	4.55e-05	0.000152	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.54e-05	0.000152	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSTP1—Parkinson's disease	4.52e-05	0.000151	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSTP1—Parkinson's disease	4.52e-05	0.000151	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—MAOA—Parkinson's disease	4.51e-05	0.000151	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—MAOA—Parkinson's disease	4.51e-05	0.000151	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.51e-05	0.00015	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—HMOX1—Parkinson's disease	4.46e-05	0.000149	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—HMOX1—Parkinson's disease	4.46e-05	0.000149	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	4.46e-05	0.000149	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—MAG—Parkinson's disease	4.45e-05	0.000149	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.44e-05	0.000148	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.41e-05	0.000147	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	4.39e-05	0.000147	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	4.38e-05	0.000146	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.36e-05	0.000146	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TALDO1—Parkinson's disease	4.35e-05	0.000145	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—OMD—Parkinson's disease	4.35e-05	0.000145	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.34e-05	0.000145	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.33e-05	0.000144	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—ABCB1—Parkinson's disease	4.28e-05	0.000143	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—ABCB1—Parkinson's disease	4.28e-05	0.000143	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.26e-05	0.000142	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.26e-05	0.000142	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.24e-05	0.000142	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.23e-05	0.000141	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.2e-05	0.00014	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.16e-05	0.000139	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GSTM1—Parkinson's disease	4.16e-05	0.000139	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GSTM1—Parkinson's disease	4.16e-05	0.000139	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.16e-05	0.000139	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.15e-05	0.000138	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NDUFB11—Parkinson's disease	4.12e-05	0.000138	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	4.09e-05	0.000137	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.09e-05	0.000137	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.06e-05	0.000136	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	4.04e-05	0.000135	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.03e-05	0.000135	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.99e-05	0.000133	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GPX1—Parkinson's disease	3.98e-05	0.000133	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GPX1—Parkinson's disease	3.98e-05	0.000133	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.98e-05	0.000133	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	3.97e-05	0.000133	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GCH1—Parkinson's disease	3.93e-05	0.000131	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	3.84e-05	0.000128	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.79e-05	0.000127	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MCCC1—Parkinson's disease	3.73e-05	0.000125	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ND3—Parkinson's disease	3.73e-05	0.000125	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.68e-05	0.000123	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—MTHFR—Parkinson's disease	3.67e-05	0.000123	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—MTHFR—Parkinson's disease	3.67e-05	0.000123	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ND3—Parkinson's disease	3.65e-05	0.000122	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MCCC1—Parkinson's disease	3.65e-05	0.000122	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.64e-05	0.000122	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.63e-05	0.000121	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TNF—Parkinson's disease	3.63e-05	0.000121	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	3.62e-05	0.000121	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.62e-05	0.000121	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	3.6e-05	0.00012	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.56e-05	0.000119	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.54e-05	0.000118	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.53e-05	0.000118	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TALDO1—Parkinson's disease	3.51e-05	0.000117	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—OMD—Parkinson's disease	3.51e-05	0.000117	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—FBP1—Parkinson's disease	3.5e-05	0.000117	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—DBH—Parkinson's disease	3.5e-05	0.000117	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GBA—Parkinson's disease	3.5e-05	0.000117	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.49e-05	0.000116	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.47e-05	0.000116	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.47e-05	0.000116	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	3.45e-05	0.000115	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TALDO1—Parkinson's disease	3.44e-05	0.000115	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—OMD—Parkinson's disease	3.44e-05	0.000115	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—APOE—Parkinson's disease	3.42e-05	0.000114	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—APOE—Parkinson's disease	3.42e-05	0.000114	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.41e-05	0.000114	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	3.4e-05	0.000114	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.39e-05	0.000113	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.34e-05	0.000111	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.33e-05	0.000111	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NDUFB11—Parkinson's disease	3.33e-05	0.000111	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	3.26e-05	0.000109	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	3.18e-05	0.000106	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GCH1—Parkinson's disease	3.17e-05	0.000106	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	3.17e-05	0.000106	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	3.16e-05	0.000105	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MCCC1—Parkinson's disease	3.14e-05	0.000105	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ND3—Parkinson's disease	3.14e-05	0.000105	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.11e-05	0.000104	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GCH1—Parkinson's disease	3.11e-05	0.000104	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.03e-05	0.000101	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TALDO1—Parkinson's disease	2.95e-05	9.86e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—OMD—Parkinson's disease	2.95e-05	9.86e-05	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—IL6—Parkinson's disease	2.93e-05	9.78e-05	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—INS—Parkinson's disease	2.92e-05	9.76e-05	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—INS—Parkinson's disease	2.92e-05	9.76e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	2.92e-05	9.75e-05	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.91e-05	9.72e-05	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	2.88e-05	9.62e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—DBH—Parkinson's disease	2.83e-05	9.44e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—FBP1—Parkinson's disease	2.83e-05	9.44e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GBA—Parkinson's disease	2.83e-05	9.44e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—FGB—Parkinson's disease	2.81e-05	9.37e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NDUFB11—Parkinson's disease	2.8e-05	9.35e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GBA—Parkinson's disease	2.77e-05	9.25e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—FBP1—Parkinson's disease	2.77e-05	9.25e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—DBH—Parkinson's disease	2.77e-05	9.25e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GCH1—Parkinson's disease	2.67e-05	8.92e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—COMT—Parkinson's disease	2.61e-05	8.73e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	2.6e-05	8.69e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	2.6e-05	8.67e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	2.58e-05	8.61e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—DDC—Parkinson's disease	2.57e-05	8.59e-05	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.57e-05	8.58e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	2.57e-05	8.57e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTA4—Parkinson's disease	2.43e-05	8.11e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.41e-05	8.04e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	2.39e-05	7.99e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GBA—Parkinson's disease	2.38e-05	7.95e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—FBP1—Parkinson's disease	2.38e-05	7.95e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—DBH—Parkinson's disease	2.38e-05	7.95e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	2.36e-05	7.88e-05	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	2.33e-05	7.77e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PLA2G6—Parkinson's disease	2.19e-05	7.3e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—MAOB—Parkinson's disease	2.17e-05	7.23e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SOD1—Parkinson's disease	2.08e-05	6.96e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.08e-05	6.95e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—DDC—Parkinson's disease	2.08e-05	6.93e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—DDC—Parkinson's disease	2.03e-05	6.79e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2e-05	6.67e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—ABL1—Parkinson's disease	1.99e-05	6.64e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IGF2—Parkinson's disease	1.98e-05	6.61e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTA4—Parkinson's disease	1.96e-05	6.54e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTA4—Parkinson's disease	1.92e-05	6.41e-05	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HGF—Parkinson's disease	1.87e-05	6.24e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	1.76e-05	5.89e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—DDC—Parkinson's disease	1.75e-05	5.83e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MAOB—Parkinson's disease	1.75e-05	5.83e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.74e-05	5.8e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	1.73e-05	5.77e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MAOB—Parkinson's disease	1.71e-05	5.71e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ND3—Parkinson's disease	1.7e-05	5.66e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.7e-05	5.66e-05	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.67e-05	5.56e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTA4—Parkinson's disease	1.65e-05	5.51e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.63e-05	5.44e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP2D6—Parkinson's disease	1.61e-05	5.37e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—OMD—Parkinson's disease	1.59e-05	5.32e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.59e-05	5.32e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CTGF—Parkinson's disease	1.58e-05	5.27e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.51e-05	5.05e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PLA2G6—Parkinson's disease	1.49e-05	4.96e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	1.47e-05	4.91e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MAOB—Parkinson's disease	1.47e-05	4.91e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NQO1—Parkinson's disease	1.46e-05	4.86e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.44e-05	4.81e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TH—Parkinson's disease	1.43e-05	4.79e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.4e-05	4.67e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CYCS—Parkinson's disease	1.38e-05	4.6e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	1.3e-05	4.34e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.28e-05	4.29e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—DBH—Parkinson's disease	1.28e-05	4.29e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GBA—Parkinson's disease	1.28e-05	4.29e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CTGF—Parkinson's disease	1.27e-05	4.26e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.27e-05	4.25e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.25e-05	4.17e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—COMT—Parkinson's disease	1.22e-05	4.07e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTP1—Parkinson's disease	1.21e-05	4.05e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—MAOA—Parkinson's disease	1.21e-05	4.04e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—HMOX1—Parkinson's disease	1.2e-05	4e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	1.19e-05	3.97e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NQO1—Parkinson's disease	1.17e-05	3.92e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TH—Parkinson's disease	1.16e-05	3.86e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.15e-05	3.84e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ABCB1—Parkinson's disease	1.15e-05	3.84e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TH—Parkinson's disease	1.13e-05	3.78e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GSTM1—Parkinson's disease	1.12e-05	3.72e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CYCS—Parkinson's disease	1.11e-05	3.71e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP2D6—Parkinson's disease	1.09e-05	3.65e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.09e-05	3.63e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CTGF—Parkinson's disease	1.07e-05	3.58e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GPX1—Parkinson's disease	1.07e-05	3.57e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYP2E1—Parkinson's disease	1e-05	3.34e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NQO1—Parkinson's disease	9.88e-06	3.3e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—MTHFR—Parkinson's disease	9.86e-06	3.29e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—COMT—Parkinson's disease	9.84e-06	3.29e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTP1—Parkinson's disease	9.79e-06	3.27e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MAOA—Parkinson's disease	9.77e-06	3.26e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TH—Parkinson's disease	9.74e-06	3.25e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—HMOX1—Parkinson's disease	9.66e-06	3.23e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—COMT—Parkinson's disease	9.64e-06	3.22e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTP1—Parkinson's disease	9.59e-06	3.2e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MAOA—Parkinson's disease	9.57e-06	3.2e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—HMOX1—Parkinson's disease	9.46e-06	3.16e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—DDC—Parkinson's disease	9.43e-06	3.15e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CYCS—Parkinson's disease	9.35e-06	3.12e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCB1—Parkinson's disease	9.27e-06	3.1e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—APOE—Parkinson's disease	9.18e-06	3.06e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCB1—Parkinson's disease	9.08e-06	3.03e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GSTM1—Parkinson's disease	9e-06	3.01e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTA4—Parkinson's disease	8.91e-06	2.97e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GSTM1—Parkinson's disease	8.81e-06	2.94e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GPX1—Parkinson's disease	8.62e-06	2.88e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GPX1—Parkinson's disease	8.44e-06	2.82e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—COMT—Parkinson's disease	8.28e-06	2.77e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTP1—Parkinson's disease	8.24e-06	2.75e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MAOA—Parkinson's disease	8.22e-06	2.75e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—HMOX1—Parkinson's disease	8.13e-06	2.71e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	8.02e-06	2.68e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—MTHFR—Parkinson's disease	7.95e-06	2.66e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MAOB—Parkinson's disease	7.94e-06	2.65e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—INS—Parkinson's disease	7.84e-06	2.62e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCB1—Parkinson's disease	7.8e-06	2.61e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—MTHFR—Parkinson's disease	7.79e-06	2.6e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GSTM1—Parkinson's disease	7.58e-06	2.53e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—APOE—Parkinson's disease	7.4e-06	2.47e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GPX1—Parkinson's disease	7.25e-06	2.42e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—APOE—Parkinson's disease	7.25e-06	2.42e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—MTHFR—Parkinson's disease	6.69e-06	2.24e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—INS—Parkinson's disease	6.33e-06	2.11e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—APOE—Parkinson's disease	6.23e-06	2.08e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—INS—Parkinson's disease	6.2e-06	2.07e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.9e-06	1.97e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.79e-06	1.93e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.4e-06	1.8e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.34e-06	1.78e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—INS—Parkinson's disease	5.32e-06	1.78e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TH—Parkinson's disease	5.26e-06	1.76e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.05e-06	1.69e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—COMT—Parkinson's disease	4.47e-06	1.49e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.45e-06	1.49e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.44e-06	1.48e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.39e-06	1.47e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.21e-06	1.41e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.09e-06	1.37e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.92e-06	1.31e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.61e-06	1.21e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—APOE—Parkinson's disease	3.36e-06	1.12e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—INS—Parkinson's disease	2.87e-06	9.6e-06	CbGpPWpGaD
